EUVIMEDEUVIMED entdecken
Crossref

Genetically Engineered Glycosylphosphatidylinositol-Anchored Anti-GD2 Nanobody-Exosome Mimetics for Targeted Osteosarcoma Therapy In Vitro and In Vivo

Jinkui Wang iD, Mujie Li, Zhaoxia Zhang, Tao Mi, Junyi Luo, Dawei He

ACS Applied Materials & Interfaces · 15.10.2025 · 17 (41) · 56749-56761

DOI: 10.1021/acsami.5c12922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 02.10.2025. Verfasst von Jinkui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China. Hauptthemen laut MEDLINE: Osteosarcoma, Glycosylphosphatidylinositols, Single-Domain Antibodies, Gangliosides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Chongqing Municipal Science and Technology Bureau, Chongqing medical scientific research project, Project of Chongqing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaGlycosylphosphatidylinositolsSingle-Domain AntibodiesGangliosidesExosomesBone NeoplasmsAntineoplastic AgentsHumansAnimalsMiceHEK293 CellsMice, NudeCell Line, TumorGenetic Engineering

Stichwörter der Autor:innen

disialogangliosideexosome mimeticsglycosylphosphatidylinositol anchornanobodyosteosarcoma

Substanzen

GlycosylphosphatidylinositolsSingle-Domain AntibodiesGangliosidesganglioside, GD2Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pediatrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Key Laboratory of Integrated Therapy of Traditional Chinese Medicine for Tumors, Chongqing Municipal Administration of Traditional Chinese Medicine, Chongqing 400010, China.
  • Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing 400000, China.

ORCID-Profile: Jinkui Wang

Förderung

  • Chongqing Municipal Science and Technology Bureau
  • Chongqing medical scientific research project
  • Project of Chongqing Natural Science Foundation
  • The Chongqing Traditional Chinese Medicine Innovation Team

Zitieren

APA

Wang, J., Li, M., Zhang, Z., Mi, T., Luo, J., & He, D. (2025). Genetically Engineered Glycosylphosphatidylinositol-Anchored Anti-GD2 Nanobody-Exosome Mimetics for Targeted Osteosarcoma Therapy In Vitro and In Vivo. ACS Applied Materials & Interfaces, 17(41), 56749-56761. https://doi.org/10.1021/acsami.5c12922

Vancouver

Wang J, Li M, Zhang Z, Mi T, Luo J, He D. Genetically Engineered Glycosylphosphatidylinositol-Anchored Anti-GD2 Nanobody-Exosome Mimetics for Targeted Osteosarcoma Therapy In Vitro and In Vivo. ACS Applied Materials & Interfaces. 2025;17(41):56749-56761. doi:10.1021/acsami.5c12922

BibTeX
@article{Wang2025,
  author = {Wang, Jinkui and Li, Mujie and Zhang, Zhaoxia and Mi, Tao and Luo, Junyi and He, Dawei},
  title = {Genetically Engineered Glycosylphosphatidylinositol-Anchored Anti-GD2 Nanobody-Exosome Mimetics for Targeted Osteosarcoma Therapy In Vitro and In Vivo},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {41},
  pages = {56749--56761},
  doi = {10.1021/acsami.5c12922}
}
Kostenlos starten →